|
ETON | Eton Pharmaceuticals, Inc. |
|
|
ETON | Eton Pharmaceuticals, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.06 |
| Leverage | 77.87% |
| Market Cap | $ 403.6m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -6.6m |
| Margin | -9.64% |
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. The company is headquartered in Deer Park, Illinois.